KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Gilead Sciences (GILD) Shares Outstanding (2016 - 2025)

Gilead Sciences (GILD) has disclosed Shares Outstanding for 1 consecutive years, with $54109.0 as the latest value for Q4 2013.

For the quarter ending Q4 2013, Shares Outstanding changed N/A year-over-year to $54109.0, compared with a TTM value of $54109.0 through Dec 2013, changed N/A, and an annual FY2013 reading of $54109.0, changed N/A over the prior year.
Shares Outstanding was $54109.0 for Q4 2013 at Gilead Sciences.
Across five years, Shares Outstanding topped out at $54109.0 in Q4 2013 and bottomed at $54109.0 in Q4 2013.